Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by tuesdaynightridon Nov 03, 2015 7:29am

124 Views

Post# 24252863

RE:RE:RE:RE:RE:RE:Theralase vs Telesta: Telesta = 6.1x the value of Theralase

Fred,

To be fair, I usually quote the CEO directly.
In this case, knowing that wounded knee was a long, I took the stated delay to February as fact.

i still have no reason to doubt his word and maybe someone else can verify.

Bullboard Posts

Micron Technology expands Crucial portfolio at CES 2025